DeepMed Research

Abramson Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.pennmedicine.org

Clinical Trials

Shared Decision-making and Colorectal Cancer Screening

Not Applicable

Recruiting

Conditions: Colorectal Cancer

Interventions: Other: CRC decision aid pamphlet
Other: Home Safety Pamphlet

First Posted Date: 2021-02-10

Last Posted Date: 2025-03-05

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 60

Registration Number: NCT04748380

Locations: 🇺🇸
University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States

Improving Tobacco Treatment Rates for Cancer Patients Who Smoke

Not Applicable

Completed

Conditions: Cancer
Tobacco Use
Nicotine Dependence
Smoking

Interventions: Other: Tobacco Use Treatment Service and Varenicline Management

First Posted Date: 2021-02-04

Last Posted Date: 2025-05-08

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 685

Registration Number: NCT04738643

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, United States

Pilot Study of an NTproBNP Guided Strategy of Cardioprotection

Phase 1

Active, not recruiting

Conditions: Lymphoma
Cardiomyopathies
Cardiotoxicity
Breast Cancer
Heart Failure
Toxicity Due to Chemotherapy

First Posted Date: 2021-02-03

Last Posted Date: 2024-10-15

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 101

Registration Number: NCT04737265

Locations: 🇺🇸
City of Hope, Duarte, California, United States
🇺🇸
Abramson Cancer Center at University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Chester County Hospital, West Chester, Pennsylvania, United States

Improving Tobacco Treatment Rates for Outpatient Cancer Patients Who Smoke

Not Applicable

Completed

Conditions: Smoking
Tobacco Use
Cancer
Nicotine Dependence

Interventions: Other: Clinician Nudge
Other: Patient Nudge

First Posted Date: 2021-02-03

Last Posted Date: 2024-02-13

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 2146

Registration Number: NCT04737031

Locations: 🇺🇸
Lancaster General Hospital, Lancaster, Pennsylvania, United States
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Chester County Hospital, West Chester, Pennsylvania, United States

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers

Not Applicable

Completed

Conditions: Gastrointestinal Cancer

Interventions: Device: Pharmacogenetic test

First Posted Date: 2021-02-03

Last Posted Date: 2024-10-18

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 316

Registration Number: NCT04736472

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Lancaster General Hospital, Lancaster, Pennsylvania, United States
🇺🇸
Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, United States

Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer

Phase 2

Completed

Conditions: Non-Small Cell Lung Cancer
KRAS Mutation-Related Tumors

Interventions: Drug: Binimetinib Pill
Drug: Hydroxychloroquine Pill

First Posted Date: 2021-02-02

Last Posted Date: 2025-04-01

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 9

Registration Number: NCT04735068

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting

Not Applicable

Completed

Conditions: Colorectal Cancer

Interventions: Behavioral: Choice
Behavioral: Colonoscopy Only
Behavioral: FIT Only

First Posted Date: 2021-01-15

Last Posted Date: 2023-01-13

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 800

Registration Number: NCT04711473

Locations: 🇺🇸
Community Health and Dental Care, Pottstown, Pennsylvania, United States

Functional Lung Imaging With DECT and 4DCT

Completed

Conditions: Non Small Cell Lung Cancer

Interventions: Procedure: contrast enhanced 4DCT

First Posted Date: 2021-01-11

Last Posted Date: 2024-11-05

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 40

Registration Number: NCT04702607

Locations: 🇺🇸
Abamson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy

Phase 1

Recruiting

Conditions: Lung Cancer, Nonsmall Cell

Interventions: Drug: Atezolizumab
Drug: Tocilizumab

First Posted Date: 2020-12-31

Last Posted Date: 2025-01-22

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 28

Registration Number: NCT04691817

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

PROStep: A Feasibility Trial Using PROs and Step Data to Monitor Patients With Lung and GI Cancers

Phase 3

Completed

Conditions: Lung Cancer
Gastro-intestinal
Cancer

Interventions: Other: PRO questionnaire
Other: Step monitoring
Other: PROStep Dashboard (clinicians)
Other: Active nudge text feedback

First Posted Date: 2020-11-05

Last Posted Date: 2022-03-03

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 109

Registration Number: NCT04616768

Locations: 🇺🇸
Perelman Center for Advanced Medicine (PCAM), Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy